Production and evaluation of a monoclonal antibody to Clostridium perfringens type D epsilon toxin

M I El-Enbaawy1, Y A Abdalla, A Z Hussein

  • 1Microbiology Department, Faculty of Veterinary Medicine, Cairo University Abbasia, Cairo, Egypt.

Insights

A new monoclonal antibody effectively neutralizes Clostridium perfringens type D epsilon toxin. This antibody enables a competitive ELISA test that correlates with traditional mouse neutralization tests for vaccine evaluation.

Area of Science:

  • Veterinary immunology
  • Monoclonal antibody development
  • Toxin neutralization

Background:

  • Clostridium perfringens type D epsilon toxin is a potent lethal agent.
  • Accurate assessment of antitoxin levels is crucial for vaccine efficacy.
  • Existing neutralization tests can be resource-intensive.

Purpose of the Study:

  • To produce and characterize a monoclonal antibody against C. perfringens type D epsilon toxin.
  • To develop a competitive ELISA (C-ELISA) using the monoclonal antibody for antitoxin detection.
  • To validate the C-ELISA against a conventional mouse neutralization test (MNT).

Main Methods:

  • Monoclonal antibody production in hybridoma and ascitic fluid.
  • Western blot analysis to confirm antibody specificity for epsilon toxin.
  • Mouse neutralization test (MNT) to assess in vivo efficacy.
  • Competitive ELISA (C-ELISA) development and validation using vaccinated rabbit sera.

Main Results:

  • A specific monoclonal antibody was successfully generated against epsilon toxin.
  • The monoclonal antibody demonstrated efficient neutralization of epsilon toxin's lethal effects in mice.
  • The developed C-ELISA showed a strong correlation with the MNT for quantifying antitoxin levels.

Conclusions:

  • The developed monoclonal antibody is a valuable tool for neutralizing C. perfringens type D epsilon toxin.
  • The mAb-based C-ELISA provides a reliable and potentially more accessible method for evaluating C. perfringens type D vaccines.
  • This C-ELISA offers a promising alternative to traditional MNT for routine antitoxin assessment.